Document and Entity Information
Document and Entity Information | 3 Months Ended |
Mar. 31, 2024 shares | |
Cover | |
Document Type | 10-Q |
Document Quarterly Report | true |
Document Period End Date | Mar. 31, 2024 |
Document Transition Report | false |
Entity File Number | 1-9576 |
Entity Registrant Name | O-I GLASS, INC. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 22-2781933 |
Entity Address, Address Line One | One Michael Owens Way |
Entity Address, City or Town | Perrysburg |
Entity Address, State or Province | OH |
Entity Address, Postal Zip Code | 43551 |
City Area Code | 567 |
Local Phone Number | 336-5000 |
Title of 12(b) Security | Common Stock, $.01 par value |
Security Exchange Name | NYSE |
Trading Symbol | OI |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Small Business | false |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 155,721,710 |
Entity Central Index Key | 0000812074 |
Amendment Flag | false |
Document Fiscal Year Focus | 2024 |
Current Fiscal Year End Date | --12-31 |
Document Fiscal Period Focus | Q1 |
CONDENSED CONSOLIDATED RESULTS
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS | ||
Net sales | $ 1,593 | $ 1,831 |
Revenue, Product and Service [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember |
Cost of goods sold | $ (1,275) | $ (1,347) |
Gross profit | 318 | 484 |
Selling and administrative expense | (123) | (147) |
Research, development and engineering expense | (21) | (19) |
Interest expense, net | (78) | (68) |
Equity earnings | 25 | 30 |
Other expense, net | (4) | (10) |
Earnings before income taxes | 117 | 270 |
Provision for income taxes | (41) | (60) |
Net earnings | 76 | 210 |
Net earnings attributable to non-controlling interests | (4) | (4) |
Net earnings attributable to the Company | $ 72 | $ 206 |
Basic earnings per share: | ||
Net earnings attributable to the Company (in dollars per share) | $ 0.46 | $ 1.33 |
Weighted average shares outstanding (thousands) (in shares) | 154,273 | 154,696 |
Diluted earnings per share: | ||
Net earnings attributable to the Company (in dollars per share) | $ 0.45 | $ 1.29 |
Weighted average diluted shares outstanding (thousands) (in shares) | 158,467 | 159,094 |
CONDENSED CONSOLIDATED COMPREHE
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME | ||
Net earnings | $ 76 | $ 210 |
Other comprehensive income: | ||
Foreign currency translation adjustments | 5 | 161 |
Pension and other postretirement benefit adjustments, net of tax | 6 | (3) |
Change in fair value of derivative instruments, net of tax | 9 | (21) |
Other comprehensive income | 20 | 137 |
Total comprehensive income | 96 | 347 |
Comprehensive income attributable to noncontrolling interests | (4) | (7) |
Comprehensive income attributable to the Company | $ 92 | $ 340 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
Current assets: | |||
Cash and cash equivalents | $ 395 | $ 913 | $ 480 |
Trade receivables, net of allowance of $30 million, $30 million, and $32 million at March 31, 2024, December 31, 2023 and March 31, 2023 | 801 | 671 | 997 |
Inventories | 1,210 | 1,071 | 1,019 |
Prepaid expenses and other current assets | 254 | 229 | 256 |
Total current assets | 2,660 | 2,884 | 2,752 |
Property, plant and equipment, net | 3,551 | 3,555 | 3,062 |
Goodwill | 1,458 | 1,473 | 1,867 |
Intangibles, net | 250 | 254 | 267 |
Other assets | 1,490 | 1,503 | 1,477 |
Total assets | 9,409 | 9,669 | 9,425 |
Current liabilities: | |||
Accounts payable | 1,170 | 1,437 | 1,304 |
Short-term loans and long-term debt due within one year | 815 | 248 | 345 |
Other liabilities | 617 | 661 | 606 |
Total current liabilities | 2,602 | 2,346 | 2,255 |
Long-term debt | 4,119 | 4,698 | 4,422 |
Other long-term liabilities | 862 | 881 | 861 |
Share owners' equity | 1,826 | 1,744 | 1,887 |
Total liabilities and share owners' equity | $ 9,409 | $ 9,669 | $ 9,425 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
Trade receivables allowance | $ 30 | $ 30 | $ 32 |
CONDENSED CONSOLIDATED CASH FLO
CONDENSED CONSOLIDATED CASH FLOWS - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating activities: | ||
Net earnings | $ 76 | $ 210 |
Non-cash charges | ||
Depreciation and amortization | 125 | 118 |
Pension expense | 8 | 7 |
Stock-based compensation expense | 7 | 19 |
Other, net (a) | 19 | 1 |
Pension contributions | (3) | (6) |
Cash paid for restructuring activities | (10) | (6) |
Change in components of working capital | (492) | (536) |
Cash utilized in operating activities | (270) | (193) |
Investing activities: | ||
Cash payments for property, plant and equipment | (213) | (95) |
Contributions and advances to joint ventures | (3) | |
Net cash payments from hedging activities | (2) | |
Cash utilized in investing activities | (215) | (98) |
Financing activities: | ||
Changes in borrowings, net | 6 | (5) |
Shares repurchased | (10) | (10) |
Other, net | (13) | (1) |
Cash utilized in financing activities | (17) | (16) |
Effect of exchange rate fluctuations on cash | (16) | 14 |
Effect of exchange rate fluctuations on cash | (518) | (293) |
Cash and cash equivalents at beginning of period | 913 | 773 |
Cash and cash equivalents at end of period | $ 395 | $ 480 |
Segment Information
Segment Information | 3 Months Ended |
Mar. 31, 2024 | |
Segment Information | |
Segment Information | 1. Segment Information The Company has two reportable segments and two operating segments based on its geographic locations: the Americas and Europe. These segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the segments or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, certain equity investments and the remaining businesses in the Asia Pacific region. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments. The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations and other adjustments, as well as certain retained corporate costs. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under accounting principles generally accepted in the United States (“U.S. GAAP”) and, therefore, does not purport to be an alternative to earnings before income taxes. Further, the Company's measure of segment operating profit may not be comparable to similarly titled measures of other companies. Financial information for the three months ended March 31, 2024 and 2023 regarding the Company’s reportable segments is as follows: Three months ended March 31, 2024 2023 Net sales: Americas $ 854 $ 1,000 Europe 709 799 Reportable segment totals 1,563 1,799 Other 30 32 Net sales $ 1,593 $ 1,831 Three months ended March 31, 2024 2023 Earnings before income taxes $ 117 $ 270 Items excluded from segment operating profit: Retained corporate costs and other 40 60 Interest expense, net 78 68 Segment operating profit $ 235 $ 398 Americas $ 102 $ 176 Europe 133 222 Reportable segment totals $ 235 $ 398 Financial information regarding the Company’s total assets is as follows: March 31, December 31, March 31, 2024 2023 2023 Total assets: Americas $ 5,258 $ 5,218 $ 5,341 Europe 3,729 3,949 3,639 Reportable segment totals 8,987 9,167 8,980 Other 422 502 445 Consolidated totals $ 9,409 $ 9,669 $ 9,425 |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2024 | |
Revenue | |
Revenue | 2. Revenue Revenue is recognized at a point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Amounts billed to customers related to shipping and handling or other pass-through items are included in net sales in the Condensed Consolidated Results of Operations. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment. For the three-month periods ended March 31, 2024 and March 31, 2023, the Company had no material bad debt expense, and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Condensed Consolidated Balance Sheets. For the three-month periods ended March 31, 2024 and March 31, 2023, revenue recognized from prior periods was not material. The following tables for the three months ended March 31, 2024 and 2023 disaggregate the Company’s revenue by customer end use: Three months ended March 31, 2024 Americas Europe Total Alcoholic beverages (beer, wine, spirits) $ 468 $ 517 $ 985 Food and other 214 120 334 Non-alcoholic beverages 172 72 244 Reportable segment totals $ 854 $ 709 $ 1,563 Other 30 Net sales $ 1,593 Three months ended March 31, 2023 Americas Europe Total Alcoholic beverages (beer, wine, spirits) $ 609 $ 604 $ 1,213 Food and other 218 126 344 Non-alcoholic beverages 173 69 242 Reportable segment totals $ 1,000 $ 799 $ 1,799 Other 32 Net sales $ 1,831 |
Credit Losses
Credit Losses | 3 Months Ended |
Mar. 31, 2024 | |
Credit Losses | |
Credit Losses | 3. Credit Losses The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers it sells to them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness, based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue the recovery of defaulted receivables. At March 31, 2024 and March 31, 2023, the Company reported $801 million and $997 million of accounts receivable, respectively, net of allowances of $30 million and $32 million, respectively. Changes in the allowance were not material for each of the three months ended March 31, 2024 and March 31, 2023. |
Inventories
Inventories | 3 Months Ended |
Mar. 31, 2024 | |
Inventories | |
Inventories | 4. Inventories Major classes of inventory at March 31, 2024, December 31, 2023 and March 31, 2023 are as follows: March 31, December 31, March 31, 2024 2023 2023 Finished goods $ 999 $ 868 $ 800 Raw materials 159 151 171 Operating supplies 52 52 48 $ 1,210 $ 1,071 $ 1,019 |
Derivative Instruments
Derivative Instruments | 3 Months Ended |
Mar. 31, 2024 | |
Derivative Instruments | |
Derivative Instruments | 5. Derivative Instruments The Company has certain derivative assets and liabilities, which consist of natural gas forwards and collars, foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Natural gas prices, foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. Estimates of the fair value of foreign currency and commodity derivative instruments are determined using exchange traded prices and rates. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs are observable in active markets over the terms of the instruments the Company holds, and, accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. Commodity Forward Contracts and Collars Designated as Cash Flow Hedges The Company has entered into commodity forward contracts and collars related to forecasted natural gas requirements, the objective of which are to limit the effects of fluctuations in future market prices of natural gas and the related volatility in cash flows. An unrecognized loss of $8 million, $0 and $12 million at March 31, 2024, December 31, 2023 and March 31, 2023, respectively, related to the commodity forward contracts and collars was included in Accumulated other comprehensive income (loss) (“Accumulated OCI”), and will be reclassified into earnings over the next 12 months. Cash Flow Hedges of Foreign Exchange Risk The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency. In addition, one of the Company’s non-U.S. dollar-functional-currency subsidiaries purchases a raw material in the normal course of business for use in glass container production that is priced in U.S. dollars. Such purchases expose the Company to exchange rate fluctuations. The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign currency exchange risk. No unrecognized gains related to cross-currency swaps were included in Accumulated OCI, and will be reclassified into earnings within the next 12 months. Fair Value Hedges of Foreign Exchange Risk The Company has fixed and variable interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency. The Company uses derivatives to manage these exposures and designates these derivatives as fair value hedges of foreign currency exchange risk. Approximately $5 million, $2 million and $19 million of the components were excluded from the assessment of effectiveness and are included in Accumulated OCI at March 31, 2024, December 31, 2023 and March 31, 2023, respectively. Interest Rate Swaps Designated as Fair Value Hedges The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. The Company’s fixed-to-variable interest rate swaps are accounted for as fair value hedges. The relevant terms of the swap agreements match the corresponding terms of the notes, and therefore, there is no hedge ineffectiveness. The Company recorded the net of the fair market values of the swaps as a long-term liability and short-term asset, along with a corresponding net decrease in the carrying value of the hedged debt. Net Investment Hedges The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure. Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency exchange rate risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies. Balance Sheet Classification The following table shows the amount and classification (as noted above) of the Company’s derivatives at March 31, 2024, December 31, 2023 and March 31, 2023: Fair Value of Fair Value of Hedge Assets Hedge Liabilities March 31, December 31, March 31, March 31, December 31, March 31, 2024 2023 2023 2024 2023 2023 Derivatives designated as hedging instruments: Commodity forward contracts and collars (a) $ — $ — $ — $ 15 $ 14 $ 20 Interest rate swaps - fair value hedges (b) 39 Cash flow hedges of foreign exchange risk (c) 2 Fair value hedges of foreign exchange risk (d) 6 4 5 92 111 78 Net investment hedges (e) 3 4 2 41 56 34 Total derivatives accounted for as hedges $ 9 $ 8 $ 7 $ 148 $ 181 $ 173 Derivatives not designated as hedges: Foreign exchange derivative contracts (f) 1 5 8 9 9 2 Total derivatives $ 10 $ 13 $ 15 $ 157 $ 190 $ 175 Current $ 10 $ 13 $ 15 $ 17 $ 17 $ 36 Noncurrent 140 173 139 Total derivatives $ 10 $ 13 $ 15 $ 157 $ 190 $ 175 (a) The notional amount of the commodity forward contracts and collars was approximately 35 million, 38 million, and 49 million British Thermal Units (“BTUs”) at March 31, 2024, December 31, 2023, and March 31, 2023, respectively. The maximum maturity dates are in 2027 at March 31, 2024, December 31, 2023, and March 31, 2023. (b) The notional amounts of the interest rate swaps designated as fair value hedges were €0 at March 31, 2024, €0 million at December 31, 2023 and €725 million at March 31, 2023. The maximum maturity date was in 2024 at March 31, 2023. (c) The notional amounts of the cash flow hedges of foreign exchange risk were 0 Mexican pesos at March 31, 2024, 0 Mexican pesos at December 31, 2023 and 710 million Mexican pesos at March 31, 2023. The maximum maturity date was in 2023 at March 31, 2023. (d) The notional amounts of the fair value hedges of foreign exchange risk were $833 million at March 31, 2024, $833 million at December 31, 2023 and $844 million at March 31, 2023. The maximum maturity dates are in 2030 at March 31, 2024, December 31, 2023 and March 31, 2023. (e) The notional amounts of the net investment hedges were €483 million at March 31, 2024, €483 million at December 31, 2023 and €358 million at March 31, 2024. The maximum maturity dates are in 2026 at March 31, 2024, December 31, 2023 and March 31, 2024. (f) The notional amounts of the foreign exchange derivative contracts were $453 million, $407 million and $420 million at March 31, 2024, December 31, 2023 and March 31, 2023, respectively. The maximum maturity dates are in 2024 at March 31, 2024, and in 2023 at December 31, 2023 and March 31, 2023. Gain (Loss) Recognized in OCI (Effective Portion) Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) Three months ended March 31, Three months ended March 31, Derivatives designated as hedging instruments: 2024 2023 2024 2023 Cash Flow Hedges Commodity forward contracts and collars (a) $ (4) $ (18) $ (3) $ (4) Cash flow hedges of foreign exchange risk (a) (2) 1 Net Investment Hedges Net Investment Hedges (b) 15 (6) 2 1 $ 11 $ (26) $ (1) $ (2) Amount of Gain (Loss) Recognized in Other expense, net Three months ended March 31, Derivatives not designated as hedges: 2024 2023 Foreign exchange derivative contracts $ (4) $ (1) (1) Gains and losses reclassified from Accumulated OCI and recognized in income are recorded to (a) cost of goods sold or (b) interest expense, net. |
Restructuring Accruals
Restructuring Accruals | 3 Months Ended |
Mar. 31, 2024 | |
Restructuring Accruals | |
Restructuring Accruals | 6 . Restructuring Accruals Selected information related to the restructuring accruals for the three months ended March 31, 2024 and 2023 is as follows: Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2024 $ 27 $ — $ 12 $ 39 Net cash paid, principally severance and other exit costs (8) (2) (10) Balance at March 31, 2024 $ 19 $ — $ 10 $ 29 Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2023 $ 17 $ — $ 10 $ 27 Net cash paid, principally severance and related benefits (3) (3) (6) Balance at March 31, 2023 $ 14 $ — $ 7 $ 21 When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the ongoing operations of the business. Information related to major programs is presented separately, while minor initiatives are presented on a combined basis. As of March 31, 2024 and 2023, no major restructuring programs were in effect. |
Pension Benefit Plans
Pension Benefit Plans | 3 Months Ended |
Mar. 31, 2024 | |
Pension Benefit Plans | |
Pension Benefit Plans | 7. Pension Benefit Plans The components of the net periodic pension cost for the three months ended March 31, 2024 and 2023 are as follows: U.S. Non-U.S. Three months ended March 31, Three months ended March 31, 2024 2023 2024 2023 Service cost $ 1 $ 2 $ 2 $ 2 Interest cost 11 11 9 9 Expected asset return (13) (14) (8) (7) Amortization of actuarial loss 3 2 3 2 Net periodic pension cost $ 2 $ 1 $ 6 $ 6 The components of pension expense, other than the service cost component, are included in Other expense, net on the Condensed Consolidated Results of Operations. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2024 | |
Income Taxes. | |
Income Taxes | 8. Income Taxes The Company calculates its interim tax provision using the estimated annual effective tax rate (“EAETR”) methodology in accordance with ASC 740-270. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income or loss in each tax jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the quarter they occur, in accordance with U.S. GAAP. Depending on various factors, such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. The Company’s annual effective tax rate may be affected by the mix of earnings in the U.S. and foreign jurisdictions, and factors such as changes in tax laws, tax rates or regulations, changes in business, changing interpretation of existing tax laws or regulations and the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions. The annual effective tax rate differs from the statutory U.S. Federal tax rate of 21%, primarily because of varying non-U.S. tax rates and the impact of the U.S. valuation allowance. The Company is currently under income tax examination in various tax jurisdictions in which it operates, including Brazil, Colombia, France, Germany, Indonesia, Italy, Mexico, Peru, and the U.S. The years under examination range from 2004 through 2022. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies, such as appeals and litigation, if necessary. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact on the Company’s consolidated results of operations, financial position or cash flows. |
Debt
Debt | 3 Months Ended |
Mar. 31, 2024 | |
Debt | |
Debt | 9. Debt The following table summarizes the long-term debt of the Company at March 31, 2024, December 31, 2023, and March 31, 2023: March 31, December 31, March 31, 2024 2023 2023 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ — $ — $ — Term Loans: Term Loan A 1,391 1,391 1,426 Senior Notes: 5.875%, due 2023 250 3.125%, due 2024 (€58 million at March 31, 2024 and December 31, 2023 and €725 million at March 31, 2023) 62 63 754 6.375%, due 2025 299 299 298 5.375%, due 2025 17 17 299 2.875%, due 2025 (€500 million) 537 551 542 6.625%, due 2027 608 608 607 6.250%, due 2028 (€600 million) 640 656 4.750%, due 2030 396 396 396 7.250%, due 2031 682 682 Finance leases 181 174 147 Other 2 3 4 Total long-term debt 4,815 4,840 4,723 Less amounts due within one year 696 142 301 Long-term debt $ 4,119 $ 4,698 $ 4,422 The Company presents debt issuance costs in the Condensed Consolidated Balance Sheets as a deduction of the carrying amount of the related debt liability. On March 25, 2022, certain of the Company’s subsidiaries entered into a Credit Agreement and Syndicated Facility Agreement (the “Original Agreement”), which refinanced in full the previous credit agreement. The Original Agreement provided for up to billion of borrowings pursuant to term loans, revolving credit facilities and a delayed draw term loan facility. million, the proceeds of which were used, in addition to other consideration paid by the Company and/or its subsidiaries, to fund an asbestos settlement trust (the “Paddock Trust”) established in connection with the confirmed plan of reorganization of Paddock Enterprises, LLC (“Paddock”) proposed by Paddock, O-I Glass and certain other parties in Paddock’s Chapter 11 case. On August 30, 2022, certain of the Company’s subsidiaries entered into an Amendment No. 1 to its Credit Agreement and Syndicated Facility Agreement (the “Credit Agreement Amendment”), which amends the Original Agreement (as amended by the Credit Agreement Amendment, the “Credit Agreement”). The Credit Agreement Amendment provides for up to The term loans mature, and the revolving credit facilities terminate, in March 2027. At March 31, 2024, the Credit Agreement includes a $300 million revolving credit facility, a $950 million multicurrency revolving credit facility and $1.45 billion in term loan A facilities ($1.39 billion outstanding balance at March 31, 2024, net of debt issuance costs ). At March 31, 2024, the Company had unused credit of . The Credit Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations. The Credit Agreement also contains one financial maintenance covenant, a Secured Leverage Ratio (as defined in the Credit Agreement), that requires the Company not to exceed a ratio of 2.50x calculated by dividing consolidated Net Indebtedness that is then secured by Liens on property or assets of the Company and certain of its subsidiaries by Consolidated EBITDA, as each term is defined and as described in the Credit Agreement. The Secured Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Secured Leverage Ratio to exceed the specified maximum. Failure to comply with these covenants and restrictions could result in an event of default under the Credit Agreement. In such an event, the Company could not request additional borrowings under the revolving facilities, and all amounts outstanding under the Credit Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to per annum will apply to all overdue obligations under the Credit Agreement. If an event of default occurs under the Credit Agreement and the lenders cause all of the outstanding debt obligations under the Credit Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of March 31, 2024, the Company was in compliance with all covenants and restrictions in the Credit Agreement. In addition, the Company believes that it will remain in compliance for the term of the Credit Agreement and that its ability to borrow additional funds under the Credit Agreement will not be adversely affected by the covenants and restrictions. The Total Leverage Ratio (as defined in the Credit Agreement) determines pricing under the Credit Agreement. The interest rate on borrowings under the Agreement), plus an applicable margin. The applicable margin is linked to the Total Leverage Ratio. The margins range from for Base Rate loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from Obligations under the Credit Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Credit Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Credit Agreement are guaranteed by certain foreign subsidiaries of the Company. On May 11, 2023, the Company announced the commencement, by two indirect, wholly owned subsidiaries of the Company, of tender offers to purchase any and all of its outstanding (i) 5.875% Senior Notes due 2023, of which $250 million aggregate principal amount was outstanding, and (ii) 3.125% Senior Notes due 2024, of which €725 million aggregate principal amount was outstanding. On May 15, 2023, the Company announced the commencement, by an indirect wholly owned subsidiary of the Company, of a tender offer to purchase any and all of its outstanding 5.375% Senior Notes due 2025, of which $300 million aggregate principal amount was outstanding. On May 26, 2023, the Company repurchased $142 million aggregate principal amount of the outstanding 5.875% Senior Notes due 2023, €666.7 million aggregate principal amount of the outstanding 3.125% Senior Notes due 2024, and $282.8 million aggregate principal amount of the outstanding 5.375% Senior Notes due 2025. The repurchases were funded with the proceeds from the May 2023 senior notes issuances described below. The Company recorded approximately $39 million of additional interest charges related to the senior note repurchases conducted in the second quarter of 2023 for note repurchase premiums, the write-off of unamortized finance fees and the settlement of a related interest rate swap. In August 2023, the Company redeemed approximately $108 million aggregate principal amount of its 5.875% Senior Notes due 2023. At March 31, 2024, approximately €58 million and $17 million aggregate principal amounts of the 3.125% Senior Notes due 2024 and 5.375% Senior Notes due 2025, respectively, remained outstanding. In May 2023, the Company issued €600 million aggregate principal amount of senior notes that bear interest at a rate of 6.250% per annum and mature on May 15, 2028. Also, in May 2023, the Company issued $690 million aggregate principal amount of senior notes that bear interest at a rate of 7.250% per annum and mature on May 15, 2031. The senior notes were issued via a private placement and are guaranteed by certain of the Company’s subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately €593 million and $682 million, respectively, were used to redeem the aggregate principal amounts described in the May 2023 tender offers above. In order to maintain a capital structure containing appropriate amounts of fixed and floating-rate debt, the Company has entered into a series of interest rate swap agreements. These interest rate swap agreements were accounted for as fair value hedges (see Note 5 for more information). The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market. The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations and are classified as Level 1 in the fair value hierarchy. Principal Indicated Market Amount Price Fair Value Senior Notes: 3.125%, due 2024 (€58 million) $ 63 99.94 $ 63 6.375%, due 2025 300 100.52 302 5.375%, due 2025 17 100.37 17 2.875%, due 2025 (€500 million) 539 98.79 532 6.625%, due 2027 612 100.13 613 6.250%, due 2028 (€600 million) 647 104.49 676 4.750%, due 2030 400 92.01 368 7.250%, due 2031 690 101.92 703 |
Contingencies
Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Contingencies | |
Contingencies | 10. Contingencies The Company has been identified by the U.S. Environmental Protection Agency (“EPA”) or a comparable state or federal agency as a potentially responsible party (“PRP”) at a number of sites in the U.S., including certain Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“CERCLA”) (Superfund) sites, as well as sites previously owned or operated by the Company. As an identified PRP, the Company may have liability for investigation, remediation and monitoring of contamination, as well as associated penalties and natural resource damages, if any. The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites. The Company has recorded aggregate accruals of approximately as of March 31, 2024, December 31, 2023 and March 31, 2023, respectively, for estimated future remediation costs and associated penalties at these sites. The majority of these accruals arose from the reconsolidation of Paddock in 2022. At the end of the first quarter of 2024, the Company began sampling at one site at which it has been named a PRP. This sampling may inform future remediation at this site, but at this stage, the Company is unable to estimate any potential loss. Although the Company believes its accruals are adequate to cover its portion of future remediation costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flows. Any possible loss or range of potential loss that may be incurred in excess of the recorded accruals cannot be estimated. In November 2023, the Autorita Garante della Concorrenza e del Mercato (the “Italian Competition Authority”) commenced an investigation into alleged anti-competitive conduct by nine glass manufacturers and distributors in Italy, including the Company’s subsidiary based in Italy, O-I Italy SpA (“O-I Italy”), and an Italian joint venture in which O-I Italy owns a 50% interest, related to the sale of wine bottles in Italy. The Italian Competition Authority’s investigation is ongoing. To date, the Italian Competition Authority has not officially charged O-I Italy or its joint venture with any violations of competition law. If the Italian Competition Authority finds that the Company or any of its subsidiaries or joint ventures violated competition law, the Italian Competition Authority could levy fines, which could be material. At this stage, the Company is unable to predict the ultimate outcome of the investigation and any potential loss cannot be estimated. Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events. |
Share Owners' Equity
Share Owners' Equity | 3 Months Ended |
Mar. 31, 2024 | |
Share Owners' Equity | |
Share Owners' Equity | 11. Share Owners’ Equity The activity in share owners’ equity for the three months ended March 31, 2024 and 2023 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2024 $ 2 $ 3,086 (681) $ 782 $ (1,580) $ 135 $ 1,744 Reissuance of common stock (0.2 million shares) (2) 5 3 Shares repurchased (0.6 million shares) (10) (10) Stock compensation (1.9 million shares) 7 7 Net earnings 72 4 76 Other comprehensive income (loss) 20 20 Other (14) (14) Balance on March 31, 2024 $ 2 $ 3,081 $ (690) $ 854 $ (1,560) $ 139 $ 1,826 Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2023 $ 2 $ 3,079 $ (688) $ 885 $ (1,861) $ 111 $ 1,528 Issuance of common stock (0.4 million shares) 5 5 Reissuance of common stock (0.2 million shares) 4 4 Shares repurchased (0.5 million shares) (10) (10) Stock compensation (0.5 million shares) 19 19 Net earnings 206 4 210 Other comprehensive income 134 3 137 Other (6) (6) Balance on March 31, 2023 $ 2 $ 3,093 $ (690) $ 1,091 $ (1,727) $ 118 $ 1,887 During the three months ended March 31, 2024, the Company purchased 638,506 shares of its common stock for approximately $10 million. The share purchases were million anti-dilutive share repurchase program authorized by the Company’s Board of Directors that is intended to offset stock-based compensation provided to the Company’s directors, officers, and employees. Approximately The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows: Shares Outstanding (in thousands) March 31, December 31, March 31, 2024 2023 2023 Shares of common stock issued (including treasury shares) 187,083 185,009 186,417 Treasury shares 31,361 30,755 31,143 |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 3 Months Ended |
Mar. 31, 2024 | |
Accumulated Other Comprehensive Loss | |
Accumulated Other Comprehensive Loss | 12. Accumulated Other Comprehensive Loss The activity in accumulated other comprehensive loss for the three months ended March 31, 2024 and 2023 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2024 $ (949) $ (43) $ (588) $ (1,580) Change before reclassifications 5 8 (1) 12 Amounts reclassified from accumulated other comprehensive income (loss) (1) (a) 6 (b) 5 Translation effect 1 1 2 Tax effect 1 1 Other comprehensive income (loss) attributable to the Company 5 9 6 20 Balance on March 31, 2024 $ (944) $ (34) $ (582) $ (1,560) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2023 $ (1,280) $ 4 $ (585) $ (1,861) Change before reclassifications 158 (19) (1) 138 Amounts reclassified from accumulated other comprehensive income (loss) (2) (a) 4 (b) 2 Translation effect (6) (6) Other comprehensive income (loss) attributable to the Company 158 (21) (3) 134 Balance on March 31, 2023 $ (1,122) $ (17) $ (588) $ (1,727) (a) Amount is recorded to cost of goods sold and interest expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost. |
Other Expense, Net
Other Expense, Net | 3 Months Ended |
Mar. 31, 2024 | |
Other Expense, Net | |
Other Expense, net | 13. Other Expense, Net Other expense, net for the three months ended March 31, 2024 and 2023 included the following: Three months ended March 31, 2024 2023 Intangible amortization expense $ (8) $ (8) Foreign currency exchange loss (3) 1 Royalty income 6 7 Other income (expense) 1 (10) Other expense, net $ (4) $ (10) |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share | |
Earnings Per Share | 14. Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2024 and 2023: Three months ended March 31, 2024 2023 Numerator: Net earnings attributable to the Company $ 72 $ 206 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 154,273 154,696 Effect of dilutive securities: Stock options and other 4,194 4,398 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 158,467 159,094 Basic earnings per share: Net earnings attributable to the Company $ 0.46 $ 1.33 Diluted earnings per share: Net earnings attributable to the Company $ 0.45 $ 1.29 The diluted earnings per share computation for the three months ended March 31, 2024 and 2023 excludes 621,013 and 222,946 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes unvested restricted stock units and performance vested restricted share units. |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 3 Months Ended |
Mar. 31, 2024 | |
Supplemental Cash Flow Information | |
Supplemental Cash Flow Information | 15. Supplemental Cash Flow Information Income taxes paid in cash were as follows: Three months ended March 31, 2024 2023 U.S. $ 3 $ 3 Non-U.S. 33 38 Total income taxes paid in cash $ 36 $ 41 Interest paid in cash for the three months ended March 31, 2024 and 2023 was $78 million and $68 million, respectively. The Company uses various factoring programs to sell certain trade receivables to financial institutions as part of managing its cash flows. Sales of trade receivables are accounted for in accordance with ASC Topic 860, Transfers and Servicing. Trade receivables sold under the factoring programs are transferred without recourse to the Company and accounted for as true sales and, therefore, are excluded from Trade receivables, net in the Condensed Consolidated Balance Sheets. At March 31, 2024, December 31, 2023 and March 31, 2023, the total amount of trade receivables sold by the Company was million at March 31, 2024, December 31, 2023, and March 31, 2023, respectively, for trade receivable amounts factored under supply-chain financing programs linked to commercial arrangements with key customers. The Company is the master servicer for the factoring programs that are not associated with key customers and is responsible for administering and collecting receivables. The Company’s use of its factoring programs resulted in a decrease in cash provided by operating activities of approximately $17 million for the three months ended March 31, 2024 and a decrease in cash provided by operating activities of approximately $20 million for the three months ended March 31, 2023. For the three months ended March 31, 2024 and 2023, the Company recorded expenses related to these factoring programs of approximately In accordance with ASU 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” the Company has agreements with third-party administrators that allow participating vendors to track the Company’s payments and, if voluntarily elected by the vendor, to sell payment obligations from the Company to financial institutions as part of a Supply Chain Financing (“SCF”) Program. The Company's payment terms to the financial institutions, including the timing and amount of payments, are based on the original supplier invoices. When participating vendors elect to sell one or more of the Company’s payment obligations, the Company’s rights and obligations to settle the payables on their contractual due date are not impacted. The Company has no economic or commercial interest in a vendor’s decision to enter into these agreements, and the financial institutions do not provide the Company with incentives, such as rebates or profit sharing under the SCF Program. The Company agrees on commercial terms with vendors for the goods and services procured, which are consistent with payment terms observed at other peer companies in the industry, and the terms are not impacted by the SCF Program. Such obligations are classified as accounts payable in its Condensed Consolidated Balance Sheets. The Company does not provide asset pledges, or other forms of guarantees, as security for the committed payment to the financial institutions. As of March 31, 2024, December 31, 2023 and March 31, 2023, the Company had approximately $94 million, $113 million, and $120 million, respectively, of outstanding payment obligations to the financial institutions as part of the SCF Program. |
Segment Information (Tables)
Segment Information (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Segment Information | |
Schedule of net sales for the Company's reportable segments | Three months ended March 31, 2024 2023 Net sales: Americas $ 854 $ 1,000 Europe 709 799 Reportable segment totals 1,563 1,799 Other 30 32 Net sales $ 1,593 $ 1,831 |
Schedule of segment operating profit (loss) for the Company's reportable segments | Three months ended March 31, 2024 2023 Earnings before income taxes $ 117 $ 270 Items excluded from segment operating profit: Retained corporate costs and other 40 60 Interest expense, net 78 68 Segment operating profit $ 235 $ 398 Americas $ 102 $ 176 Europe 133 222 Reportable segment totals $ 235 $ 398 |
Total assets for the Company's reportable segments | March 31, December 31, March 31, 2024 2023 2023 Total assets: Americas $ 5,258 $ 5,218 $ 5,341 Europe 3,729 3,949 3,639 Reportable segment totals 8,987 9,167 8,980 Other 422 502 445 Consolidated totals $ 9,409 $ 9,669 $ 9,425 |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Revenue | |
Schedule of disaggregation of revenue by customer end use | Three months ended March 31, 2024 Americas Europe Total Alcoholic beverages (beer, wine, spirits) $ 468 $ 517 $ 985 Food and other 214 120 334 Non-alcoholic beverages 172 72 244 Reportable segment totals $ 854 $ 709 $ 1,563 Other 30 Net sales $ 1,593 Three months ended March 31, 2023 Americas Europe Total Alcoholic beverages (beer, wine, spirits) $ 609 $ 604 $ 1,213 Food and other 218 126 344 Non-alcoholic beverages 173 69 242 Reportable segment totals $ 1,000 $ 799 $ 1,799 Other 32 Net sales $ 1,831 |
Inventories (Tables)
Inventories (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Inventories | |
Schedule of major classes of inventory | March 31, December 31, March 31, 2024 2023 2023 Finished goods $ 999 $ 868 $ 800 Raw materials 159 151 171 Operating supplies 52 52 48 $ 1,210 $ 1,071 $ 1,019 |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Derivative Instruments | |
Balance Sheet Classification of derivative instruments | Fair Value of Fair Value of Hedge Assets Hedge Liabilities March 31, December 31, March 31, March 31, December 31, March 31, 2024 2023 2023 2024 2023 2023 Derivatives designated as hedging instruments: Commodity forward contracts and collars (a) $ — $ — $ — $ 15 $ 14 $ 20 Interest rate swaps - fair value hedges (b) 39 Cash flow hedges of foreign exchange risk (c) 2 Fair value hedges of foreign exchange risk (d) 6 4 5 92 111 78 Net investment hedges (e) 3 4 2 41 56 34 Total derivatives accounted for as hedges $ 9 $ 8 $ 7 $ 148 $ 181 $ 173 Derivatives not designated as hedges: Foreign exchange derivative contracts (f) 1 5 8 9 9 2 Total derivatives $ 10 $ 13 $ 15 $ 157 $ 190 $ 175 Current $ 10 $ 13 $ 15 $ 17 $ 17 $ 36 Noncurrent 140 173 139 Total derivatives $ 10 $ 13 $ 15 $ 157 $ 190 $ 175 (a) The notional amount of the commodity forward contracts and collars was approximately 35 million, 38 million, and 49 million British Thermal Units (“BTUs”) at March 31, 2024, December 31, 2023, and March 31, 2023, respectively. The maximum maturity dates are in 2027 at March 31, 2024, December 31, 2023, and March 31, 2023. (b) The notional amounts of the interest rate swaps designated as fair value hedges were €0 at March 31, 2024, €0 million at December 31, 2023 and €725 million at March 31, 2023. The maximum maturity date was in 2024 at March 31, 2023. (c) The notional amounts of the cash flow hedges of foreign exchange risk were 0 Mexican pesos at March 31, 2024, 0 Mexican pesos at December 31, 2023 and 710 million Mexican pesos at March 31, 2023. The maximum maturity date was in 2023 at March 31, 2023. (d) The notional amounts of the fair value hedges of foreign exchange risk were $833 million at March 31, 2024, $833 million at December 31, 2023 and $844 million at March 31, 2023. The maximum maturity dates are in 2030 at March 31, 2024, December 31, 2023 and March 31, 2023. (e) The notional amounts of the net investment hedges were €483 million at March 31, 2024, €483 million at December 31, 2023 and €358 million at March 31, 2024. The maximum maturity dates are in 2026 at March 31, 2024, December 31, 2023 and March 31, 2024. (f) The notional amounts of the foreign exchange derivative contracts were $453 million, $407 million and $420 million at March 31, 2024, December 31, 2023 and March 31, 2023, respectively. The maximum maturity dates are in 2024 at March 31, 2024, and in 2023 at December 31, 2023 and March 31, 2023. |
Effects of derivative instruments on the results of operations | |
Restructuring Accruals (Tables)
Restructuring Accruals (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Restructuring Accruals | |
Selected information related to the restructuring accruals | Selected information related to the restructuring accruals for the three months ended March 31, 2024 and 2023 is as follows: Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2024 $ 27 $ — $ 12 $ 39 Net cash paid, principally severance and other exit costs (8) (2) (10) Balance at March 31, 2024 $ 19 $ — $ 10 $ 29 Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2023 $ 17 $ — $ 10 $ 27 Net cash paid, principally severance and related benefits (3) (3) (6) Balance at March 31, 2023 $ 14 $ — $ 7 $ 21 |
Pension Benefit Plans (Tables)
Pension Benefit Plans (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Pension Benefit Plans. | |
Defined Benefit Plans and Other Postretirement Benefit Plans | |
Components of net periodic pension cost | The components of the net periodic pension cost for the three months ended March 31, 2024 and 2023 are as follows: U.S. Non-U.S. Three months ended March 31, Three months ended March 31, 2024 2023 2024 2023 Service cost $ 1 $ 2 $ 2 $ 2 Interest cost 11 11 9 9 Expected asset return (13) (14) (8) (7) Amortization of actuarial loss 3 2 3 2 Net periodic pension cost $ 2 $ 1 $ 6 $ 6 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Debt | |
Long-term Debt | March 31, December 31, March 31, 2024 2023 2023 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ — $ — $ — Term Loans: Term Loan A 1,391 1,391 1,426 Senior Notes: 5.875%, due 2023 250 3.125%, due 2024 (€58 million at March 31, 2024 and December 31, 2023 and €725 million at March 31, 2023) 62 63 754 6.375%, due 2025 299 299 298 5.375%, due 2025 17 17 299 2.875%, due 2025 (€500 million) 537 551 542 6.625%, due 2027 608 608 607 6.250%, due 2028 (€600 million) 640 656 4.750%, due 2030 396 396 396 7.250%, due 2031 682 682 Finance leases 181 174 147 Other 2 3 4 Total long-term debt 4,815 4,840 4,723 Less amounts due within one year 696 142 301 Long-term debt $ 4,119 $ 4,698 $ 4,422 |
Fair values of the Company's significant fixed rate debt obligations | Principal Indicated Market Amount Price Fair Value Senior Notes: 3.125%, due 2024 (€58 million) $ 63 99.94 $ 63 6.375%, due 2025 300 100.52 302 5.375%, due 2025 17 100.37 17 2.875%, due 2025 (€500 million) 539 98.79 532 6.625%, due 2027 612 100.13 613 6.250%, due 2028 (€600 million) 647 104.49 676 4.750%, due 2030 400 92.01 368 7.250%, due 2031 690 101.92 703 |
Share Owners' Equity (Tables)
Share Owners' Equity (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Share Owners' Equity | |
Activity in share owner's equity | The activity in share owners’ equity for the three months ended March 31, 2024 and 2023 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2024 $ 2 $ 3,086 (681) $ 782 $ (1,580) $ 135 $ 1,744 Reissuance of common stock (0.2 million shares) (2) 5 3 Shares repurchased (0.6 million shares) (10) (10) Stock compensation (1.9 million shares) 7 7 Net earnings 72 4 76 Other comprehensive income (loss) 20 20 Other (14) (14) Balance on March 31, 2024 $ 2 $ 3,081 $ (690) $ 854 $ (1,560) $ 139 $ 1,826 Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2023 $ 2 $ 3,079 $ (688) $ 885 $ (1,861) $ 111 $ 1,528 Issuance of common stock (0.4 million shares) 5 5 Reissuance of common stock (0.2 million shares) 4 4 Shares repurchased (0.5 million shares) (10) (10) Stock compensation (0.5 million shares) 19 19 Net earnings 206 4 210 Other comprehensive income 134 3 137 Other (6) (6) Balance on March 31, 2023 $ 2 $ 3,093 $ (690) $ 1,091 $ (1,727) $ 118 $ 1,887 |
Schedule of shares outstanding | Shares Outstanding (in thousands) March 31, December 31, March 31, 2024 2023 2023 Shares of common stock issued (including treasury shares) 187,083 185,009 186,417 Treasury shares 31,361 30,755 31,143 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Loss (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Accumulated Other Comprehensive Loss | |
Component of accumulated other comprehensive income (loss) | The activity in accumulated other comprehensive loss for the three months ended March 31, 2024 and 2023 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2024 $ (949) $ (43) $ (588) $ (1,580) Change before reclassifications 5 8 (1) 12 Amounts reclassified from accumulated other comprehensive income (loss) (1) (a) 6 (b) 5 Translation effect 1 1 2 Tax effect 1 1 Other comprehensive income (loss) attributable to the Company 5 9 6 20 Balance on March 31, 2024 $ (944) $ (34) $ (582) $ (1,560) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2023 $ (1,280) $ 4 $ (585) $ (1,861) Change before reclassifications 158 (19) (1) 138 Amounts reclassified from accumulated other comprehensive income (loss) (2) (a) 4 (b) 2 Translation effect (6) (6) Other comprehensive income (loss) attributable to the Company 158 (21) (3) 134 Balance on March 31, 2023 $ (1,122) $ (17) $ (588) $ (1,727) (a) Amount is recorded to cost of goods sold and interest expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost. |
Other Expense, Net (Tables)
Other Expense, Net (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Other Expense, Net | |
Schedule of other income (expense), net | Three months ended March 31, 2024 2023 Intangible amortization expense $ (8) $ (8) Foreign currency exchange loss (3) 1 Royalty income 6 7 Other income (expense) 1 (10) Other expense, net $ (4) $ (10) |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share | |
Computation of basic and diluted earnings per share | Three months ended March 31, 2024 2023 Numerator: Net earnings attributable to the Company $ 72 $ 206 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 154,273 154,696 Effect of dilutive securities: Stock options and other 4,194 4,398 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 158,467 159,094 Basic earnings per share: Net earnings attributable to the Company $ 0.46 $ 1.33 Diluted earnings per share: Net earnings attributable to the Company $ 0.45 $ 1.29 |
Supplemental Cash Flow Inform_2
Supplemental Cash Flow Information (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Supplemental Cash Flow Information | |
Income taxes paid (received) in cash | Three months ended March 31, 2024 2023 U.S. $ 3 $ 3 Non-U.S. 33 38 Total income taxes paid in cash $ 36 $ 41 |
Segment Information (Details)
Segment Information (Details) | 3 Months Ended |
Mar. 31, 2024 segment | |
Segment Information | |
Number of reportable segments | 2 |
Number of operating segments | 2 |
Segment Information - Net Sales
Segment Information - Net Sales by Reportable Segments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Net sales: | ||
Net sales | $ 1,593 | $ 1,831 |
Reportable segment totals | ||
Net sales: | ||
Net sales | 1,563 | 1,799 |
Other | ||
Net sales: | ||
Net sales | 30 | 32 |
Americas | ||
Net sales: | ||
Net sales | 854 | 1,000 |
Americas | Reportable segment totals | ||
Net sales: | ||
Net sales | 854 | 1,000 |
Europe | ||
Net sales: | ||
Net sales | 709 | 799 |
Europe | Reportable segment totals | ||
Net sales: | ||
Net sales | $ 709 | $ 799 |
Segment Information - Segment O
Segment Information - Segment Operating Profits and Reporting Segments Totals (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Segment operating profit: | ||
Earnings before income taxes | $ 117 | $ 270 |
Items excluded from segment operating profit: | ||
Retained corporate costs and other | 40 | 60 |
Interest expense, net | 78 | 68 |
Segment operating profit | ||
Segment operating profit | 235 | 398 |
Americas | ||
Segment operating profit | ||
Segment operating profit | 102 | 176 |
Europe | ||
Segment operating profit | ||
Segment operating profit | $ 133 | $ 222 |
Segment Information - Total Ass
Segment Information - Total Assets (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
Assets | |||
Total assets: | $ 9,409 | $ 9,669 | $ 9,425 |
Reportable segment totals | |||
Assets | |||
Total assets: | 8,987 | 9,167 | 8,980 |
Other | |||
Assets | |||
Total assets: | 422 | 502 | 445 |
Americas | Reportable segment totals | |||
Assets | |||
Total assets: | 5,258 | 5,218 | 5,341 |
Europe | Reportable segment totals | |||
Assets | |||
Total assets: | $ 3,729 | $ 3,949 | $ 3,639 |
Revenue (Details)
Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue | ||
Net sales | $ 1,593 | $ 1,831 |
Reportable Segment Totals | ||
Disaggregation of Revenue | ||
Net sales | 1,563 | 1,799 |
Americas | ||
Disaggregation of Revenue | ||
Net sales | 854 | 1,000 |
Europe | ||
Disaggregation of Revenue | ||
Net sales | 709 | 799 |
Other | ||
Disaggregation of Revenue | ||
Net sales | 30 | 32 |
Alcoholic beverages (beer, wine, spirits) | ||
Disaggregation of Revenue | ||
Net sales | 985 | 1,213 |
Alcoholic beverages (beer, wine, spirits) | Americas | ||
Disaggregation of Revenue | ||
Net sales | 468 | 609 |
Alcoholic beverages (beer, wine, spirits) | Europe | ||
Disaggregation of Revenue | ||
Net sales | 517 | 604 |
Food and other | ||
Disaggregation of Revenue | ||
Net sales | 334 | 344 |
Food and other | Americas | ||
Disaggregation of Revenue | ||
Net sales | 214 | 218 |
Food and other | Europe | ||
Disaggregation of Revenue | ||
Net sales | 120 | 126 |
Non-alcoholic beverages | ||
Disaggregation of Revenue | ||
Net sales | 244 | 242 |
Non-alcoholic beverages | Americas | ||
Disaggregation of Revenue | ||
Net sales | 172 | 173 |
Non-alcoholic beverages | Europe | ||
Disaggregation of Revenue | ||
Net sales | $ 72 | $ 69 |
Credit Losses (Details)
Credit Losses (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
Credit Losses | |||
Accounts receivable, net | $ 801 | $ 671 | $ 997 |
Allowance for doubtful accounts | $ 30 | $ 30 | $ 32 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
Inventories | |||
Finished goods | $ 999 | $ 868 | $ 800 |
Raw materials | 159 | 151 | 171 |
Operating supplies | 52 | 52 | 48 |
Inventories | $ 1,210 | $ 1,071 | $ 1,019 |
Derivative Instruments - Deriva
Derivative Instruments - Derivatives and Hedges (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Commodity forward contracts and collars | Cash Flow Hedges | |||
Derivatives and Hedges | |||
Unrecognized gain (loss) included in Accumulated OCI | $ (8) | $ (12) | $ 0 |
Foreign exchange risk | Cash Flow Hedges | |||
Derivatives and Hedges | |||
Unrecognized gain (loss) included in Accumulated OCI | 0 | 0 | 0 |
Foreign exchange risk | Fair Value Hedges | |||
Derivatives and Hedges | |||
Amount excluded from assessment of effectiveness and included in Accumulated OCI | $ 5 | $ 19 | $ 2 |
Derivative Instruments - Balanc
Derivative Instruments - Balance Sheet Classification (Details) € in Millions, $ / BTU in Millions, $ in Millions, $ in Millions | 3 Months Ended | 12 Months Ended | |||||||
Mar. 31, 2024 USD ($) $ / BTU | Mar. 31, 2023 USD ($) $ / BTU | Dec. 31, 2023 USD ($) $ / BTU | Mar. 31, 2024 EUR (€) | Mar. 31, 2024 MXN ($) | Dec. 31, 2023 EUR (€) | Dec. 31, 2023 MXN ($) | Mar. 31, 2023 EUR (€) | Mar. 31, 2023 MXN ($) | |
Derivatives, Fair Value | |||||||||
Total asset derivatives | $ 10 | $ 15 | $ 13 | ||||||
Total liability derivatives | 157 | 175 | 190 | ||||||
Current derivative asset | 10 | 15 | 13 | ||||||
Current derivative liability | 17 | 36 | 17 | ||||||
Noncurrent derivative liability | 140 | 139 | 173 | ||||||
Derivatives designated as hedging instruments | |||||||||
Derivatives, Fair Value | |||||||||
Total asset derivatives | 9 | 7 | 8 | ||||||
Total liability derivatives | $ 148 | $ 173 | $ 181 | ||||||
Derivatives designated as hedging instruments | Commodity forward contracts and collars | |||||||||
Derivatives, Fair Value | |||||||||
British Thermal Units ("BTUs") | $ / BTU | 35 | 49 | 38 | ||||||
Total liability derivatives | $ 15 | $ 20 | $ 14 | ||||||
Derivatives designated as hedging instruments | Foreign exchange risk | |||||||||
Derivatives, Fair Value | |||||||||
Notional amount | 833 | 844 | 833 | ||||||
Total asset derivatives | 6 | 5 | 4 | ||||||
Total liability derivatives | 92 | 78 | 111 | ||||||
Derivatives designated as hedging instruments | Interest rate swaps - fair value hedges | |||||||||
Derivatives, Fair Value | |||||||||
Notional amount | € | € 0 | € 0 | € 725 | ||||||
Total liability derivatives | 39 | ||||||||
Derivatives designated as hedging instruments | Cash flow hedges of foreign exchange risk | |||||||||
Derivatives, Fair Value | |||||||||
Notional amount | $ 0 | $ 0 | $ 710 | ||||||
Total liability derivatives | 2 | ||||||||
Derivatives designated as hedging instruments | Net investment hedges | |||||||||
Derivatives, Fair Value | |||||||||
Notional amount | € | € 483 | € 483 | € 358 | ||||||
Total asset derivatives | 3 | 2 | 4 | ||||||
Total liability derivatives | 41 | 34 | 56 | ||||||
Derivatives not designated as hedging instruments | Foreign exchange contracts | |||||||||
Derivatives, Fair Value | |||||||||
Notional amount | 453 | 420 | 407 | ||||||
Total asset derivatives | 1 | 8 | 5 | ||||||
Total liability derivatives | $ 9 | $ 2 | $ 9 |
Derivative Instruments - Effect
Derivative Instruments - Effects of Derivative Instruments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Derivatives not designated as hedging instruments | Foreign exchange contracts | ||
Derivatives and Hedges | ||
Amount of Gain (Loss) Recognized in Other income (expense), net | $ (4) | $ (1) |
Derivatives designated as hedging instruments | ||
Derivatives and Hedges | ||
Gain (Loss) Recognized in OCI (Effective Portion) | 11 | (26) |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | (1) | (2) |
Derivatives designated as hedging instruments | Net Investment Hedges | Interest expense, net | ||
Derivatives and Hedges | ||
Gain (Loss) Recognized in OCI (Effective Portion) | 15 | (6) |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | 2 | 1 |
Derivatives designated as hedging instruments | Commodity forward contracts and collars | Cash Flow Hedges | Cost of goods sold | ||
Derivatives and Hedges | ||
Gain (Loss) Recognized in OCI (Effective Portion) | (4) | (18) |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | $ (3) | (4) |
Derivatives designated as hedging instruments | Foreign exchange risk | Cash Flow Hedges | Cost of goods sold | ||
Derivatives and Hedges | ||
Gain (Loss) Recognized in OCI (Effective Portion) | (2) | |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | $ 1 |
Restructuring Accruals (Details
Restructuring Accruals (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Restructuring accrual | ||
Beginning balance, restructuring reserve | $ 39 | $ 27 |
Net cash paid, principally severance, related benefits and other exit costs | (10) | (6) |
Ending balance, restructuring reserve | 29 | 21 |
Employee Costs | ||
Restructuring accrual | ||
Beginning balance, restructuring reserve | 27 | 17 |
Net cash paid, principally severance, related benefits and other exit costs | (8) | (3) |
Ending balance, restructuring reserve | 19 | 14 |
Other Exit Costs | ||
Restructuring accrual | ||
Beginning balance, restructuring reserve | 12 | 10 |
Net cash paid, principally severance, related benefits and other exit costs | (2) | (3) |
Ending balance, restructuring reserve | $ 10 | $ 7 |
Pension Benefit Plans (Details)
Pension Benefit Plans (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Components of net periodic pension cost | ||
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Operating Income (Expense), Net | Other Operating Income (Expense), Net |
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Operating Income (Expense), Net | Other Operating Income (Expense), Net |
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Operating Income (Expense), Net | Other Operating Income (Expense), Net |
Pension Benefit Plans. | U.S. | ||
Components of net periodic pension cost | ||
Service cost | $ 1 | $ 2 |
Interest cost | 11 | 11 |
Expected asset return | (13) | (14) |
Actuarial loss | 3 | 2 |
Net postretirement benefit (income) cost | 2 | 1 |
Pension Benefit Plans. | Non-U.S. | ||
Components of net periodic pension cost | ||
Service cost | 2 | 2 |
Interest cost | 9 | 9 |
Expected asset return | (8) | (7) |
Actuarial loss | 3 | 2 |
Net postretirement benefit (income) cost | $ 6 | $ 6 |
Income Taxes (Details)
Income Taxes (Details) | 3 Months Ended |
Mar. 31, 2024 | |
Income Taxes. | |
Statutory U.S. Federal tax rate (as a percent) | 21% |
Debt (Details)
Debt (Details) $ / shares in Units, € in Millions, $ in Millions | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||
May 31, 2023 USD ($) | May 31, 2023 EUR (€) | Mar. 31, 2024 USD ($) agreement $ / shares | Dec. 31, 2023 USD ($) | Mar. 31, 2024 EUR (€) | Dec. 31, 2023 EUR (€) | Aug. 31, 2023 USD ($) | May 31, 2023 EUR (€) | May 26, 2023 USD ($) | May 26, 2023 EUR (€) | May 15, 2023 USD ($) | May 11, 2023 USD ($) | May 11, 2023 EUR (€) | Mar. 31, 2023 USD ($) | Mar. 31, 2023 EUR (€) | Mar. 25, 2022 USD ($) | |
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 4,815 | $ 4,840 | $ 4,723 | |||||||||||||
Less amounts due within one year | 696 | 142 | 301 | |||||||||||||
Long-term debt | 4,119 | 4,698 | 4,422 | |||||||||||||
Additional interest charges for note repurchase premiums and write-off of unamortized finance fees | 39 | |||||||||||||||
Maximum Borrowing Capacity | $ 2,800 | |||||||||||||||
Secured Credit Agreement | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Unused Credit | $ 1,240 | |||||||||||||||
Number of financial maintenance covenants | agreement | 1 | |||||||||||||||
Additional default interest rate per annum applied to all obligations owed under the Agreement | 2% | |||||||||||||||
Secured Credit Agreement | Minimum | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Interest rate margin, Term SOFR loans and Euro currency rate loans | 1% | 1% | ||||||||||||||
Interest rate margin, Base Rate loans (as a percent) | 0% | |||||||||||||||
Facility fee payable (as a percent) | 0.20% | |||||||||||||||
Secured Credit Agreement | Maximum | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Interest rate margin, Term SOFR loans and Euro currency rate loans | 2.25% | 2.25% | ||||||||||||||
Interest rate margin, Base Rate loans (as a percent) | 1.25% | |||||||||||||||
Leverage Ratio | 2.50 | |||||||||||||||
Facility fee payable (as a percent) | 0.35% | |||||||||||||||
Revolving Loans | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Weighted average interest rate (as a percent) | 6.60% | 6.60% | ||||||||||||||
Term Loan A | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 1,391 | 1,391 | 1,426 | |||||||||||||
Maximum Borrowing Capacity | $ 1,450 | |||||||||||||||
Senior Notes 5.875%, due 2023 | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 108 | $ 142 | $ 250 | 250 | ||||||||||||
Interest rate, stated percentage | 5.875% | 5.875% | 5.875% | 5.875% | 5.875% | 5.875% | 5.875% | |||||||||
Senior Notes 3.125%, due 2024 (58 million EUR at December 31, 2023 and 725 million EUR at December 31, 2022) | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 62 | 63 | € 58 | € 58 | € 666.7 | € 725 | 754 | € 725 | ||||||||
Interest rate, stated percentage | 3.125% | 3.125% | 3.125% | 3.125% | 3.125% | 3.125% | ||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 63 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 99.94 | |||||||||||||||
Fair Value | $ 63 | |||||||||||||||
Senior Notes 6.375%, due 2025 | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 299 | 299 | 298 | |||||||||||||
Interest rate, stated percentage | 6.375% | 6.375% | ||||||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 300 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 100.52 | |||||||||||||||
Fair Value | $ 302 | |||||||||||||||
Senior Notes, 5.375% due 2025 | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 17 | 17 | $ 282.8 | $ 300 | 299 | |||||||||||
Interest rate, stated percentage | 5.375% | 5.375% | 5.375% | 5.375% | 5.375% | |||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 17 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 100.37 | |||||||||||||||
Fair Value | $ 17 | |||||||||||||||
Senior Notes 2.875%, due 2025 (500 million EUR) | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 537 | 551 | € 500 | € 500 | 542 | € 500 | ||||||||||
Interest rate, stated percentage | 2.875% | 2.875% | ||||||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 539 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 98.79 | |||||||||||||||
Fair Value | $ 532 | |||||||||||||||
Senior Notes 6.625%, due 2027 | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 608 | 608 | € 600 | 607 | ||||||||||||
Interest rate, stated percentage | 6.625% | 6.625% | ||||||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 612 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 100.13 | |||||||||||||||
Fair Value | $ 613 | |||||||||||||||
Senior Notes 6.250%, due 2028 (600 million EUR) | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 640 | 656 | € 600 | |||||||||||||
Interest rate, stated percentage | 6.25% | 6.25% | 6.25% | 6.25% | ||||||||||||
Net proceeds, after deducting debt issuance costs | € | € 593 | |||||||||||||||
Face value | € | € 600 | |||||||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 647 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 104.49 | |||||||||||||||
Fair Value | $ 676 | |||||||||||||||
Senior Notes 4.750%, due 2030 | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 396 | 396 | 396 | |||||||||||||
Interest rate, stated percentage | 4.75% | 4.75% | ||||||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 400 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 92.01 | |||||||||||||||
Fair Value | $ 368 | |||||||||||||||
Senior Notes 7.250% due 2031 | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | $ 682 | 682 | ||||||||||||||
Interest rate, stated percentage | 7.25% | 7.25% | 7.25% | 7.25% | ||||||||||||
Net proceeds, after deducting debt issuance costs | $ 682 | |||||||||||||||
Face value | $ 690 | |||||||||||||||
Fair values of fixed rate debt obligations | ||||||||||||||||
Principal Amount | $ 690 | |||||||||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 101.92 | |||||||||||||||
Fair Value | $ 703 | |||||||||||||||
Finance leases | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | 181 | 174 | 147 | |||||||||||||
Other debt | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Total long-term debt | 2 | $ 3 | $ 4 | |||||||||||||
Revolving Credit Facility | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Maximum Borrowing Capacity | 300 | |||||||||||||||
Delayed draw term loan facility | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Maximum Borrowing Capacity | 600 | |||||||||||||||
Term loans in aggregate | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Maximum Borrowing Capacity | $ 500 | |||||||||||||||
Multicurrency Revolving Credit Facility | ||||||||||||||||
Debt Instrument | ||||||||||||||||
Maximum Borrowing Capacity | $ 950 |
Contingencies - Other Matters (
Contingencies - Other Matters (Details) $ in Millions | Mar. 31, 2024 USD ($) | Dec. 31, 2023 USD ($) | Nov. 30, 2023 item | Mar. 31, 2023 USD ($) |
Other Matters | ||||
Loss contingency accrual | $ | $ 25 | $ 26 | $ 25 | |
O-I Ownership Percentage | O-I Italy SpA | ||||
Other Matters | ||||
Number of glass manufacturers | item | 9 | |||
General ownership percentage for equity method investments | 50% |
Share Owners' Equity - Rollforw
Share Owners' Equity - Rollforward (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Increase (Decrease) in Share Owners' Equity | ||
Balance | $ 1,744 | $ 1,528 |
Issuance of common stock | 5 | |
Reissuance of common stock | 3 | 4 |
Shares repurchased | (10) | (10) |
Stock compensation | 7 | 19 |
Net earnings | 76 | 210 |
Other comprehensive income (loss) | 20 | 137 |
Other | (14) | (6) |
Balance | 1,826 | 1,887 |
Common Stock | ||
Increase (Decrease) in Share Owners' Equity | ||
Balance | 2 | 2 |
Balance | 2 | 2 |
Capital in Excess of Par Value | ||
Increase (Decrease) in Share Owners' Equity | ||
Balance | 3,086 | 3,079 |
Issuance of common stock | 5 | |
Reissuance of common stock | (2) | |
Shares repurchased | (10) | (10) |
Stock compensation | 7 | 19 |
Balance | 3,081 | 3,093 |
Treasury Stock | ||
Increase (Decrease) in Share Owners' Equity | ||
Balance | (681) | (688) |
Reissuance of common stock | 5 | 4 |
Other | (14) | (6) |
Balance | (690) | (690) |
Retained Earnings | ||
Increase (Decrease) in Share Owners' Equity | ||
Balance | 782 | 885 |
Net earnings | 72 | 206 |
Balance | 854 | 1,091 |
Accumulated Other Comprehensive Loss. | ||
Increase (Decrease) in Share Owners' Equity | ||
Balance | (1,580) | (1,861) |
Other comprehensive income (loss) | 20 | 134 |
Balance | (1,560) | (1,727) |
Non-Controlling Interests | ||
Increase (Decrease) in Share Owners' Equity | ||
Balance | 135 | 111 |
Net earnings | 4 | 4 |
Other comprehensive income (loss) | 3 | |
Balance | $ 139 | $ 118 |
Share Owners' Equity - Rollfo_2
Share Owners' Equity - Rollforward Shares (Details) - shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Share Owners' Equity | ||
Issuance of common stock (in shares) | 400,000 | |
Reissuance of common stock (in shares) | 200,000 | 200,000 |
Shares repurchased (in shares) | 638,506 | 500,000 |
Stock compensation (in shares) | 1,900,000 | 500,000 |
Share Owners' Equity - Share Re
Share Owners' Equity - Share Repurchase (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Share Owners' Equity | ||
Shares repurchased | $ 10 | $ 10 |
Shares repurchased (in shares) | 638,506 | 500,000 |
Stock repurchase plan authorized | $ 150 | |
Remaining repurchase of common stock available | $ 20 |
Share Owners' Equity -Authoriza
Share Owners' Equity -Authorization of Common Stock (Details) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
Authorization of common stock | |||
Shares of common stock authorized | 250,000,000 | 250,000,000 | 250,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Shares of common stock issued (including treasury shares) | 187,083,000 | 185,009,000 | 186,417,000 |
Treasury shares | 31,361,000 | 30,755,000 | 31,143,000 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||
Other comprehensive income | $ 20 | $ 137 |
Net Effect of Exchange Rate Fluctuations | ||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||
Balance at beginning of the period | (949) | (1,280) |
Change before reclassifications | 5 | 158 |
Other comprehensive income | 5 | 158 |
Balance at end of the period | (944) | (1,122) |
Change in Certain Derivative Instruments | ||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||
Balance at beginning of the period | (43) | 4 |
Change before reclassifications | 8 | (19) |
Amounts reclassified from accumulated other comprehensive income | (1) | (2) |
Translation effect | 1 | |
Tax effect | 1 | |
Other comprehensive income | 9 | (21) |
Balance at end of the period | (34) | (17) |
Employee Benefit Plans | ||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||
Balance at beginning of the period | (588) | (585) |
Change before reclassifications | (1) | (1) |
Amounts reclassified from accumulated other comprehensive income | 6 | 4 |
Translation effect | 1 | (6) |
Other comprehensive income | 6 | (3) |
Balance at end of the period | (582) | (588) |
Accumulated Other Comprehensive Loss. | ||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||
Balance at beginning of the period | (1,580) | (1,861) |
Change before reclassifications | 12 | 138 |
Amounts reclassified from accumulated other comprehensive income | 5 | 2 |
Translation effect | 2 | (6) |
Tax effect | 1 | |
Other comprehensive income | 20 | 134 |
Balance at end of the period | $ (1,560) | $ (1,727) |
Other Expense, Net (Details)
Other Expense, Net (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Other Expense, Net | ||
Intangible amortization expense | $ (8) | $ (8) |
Royalty income | 6 | 7 |
Foreign currency exchange loss | (3) | 1 |
Other income (expense) | 1 | (10) |
Other expense, net | $ (4) | $ (10) |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Numerator: | ||
Net earnings (loss) attributable to the Company | $ 72 | $ 206 |
Denominator (in thousands): | ||
Denominator for basic earnings per share-weighted average shares outstanding | 154,273,000 | 154,696,000 |
Effect of dilutive securities: | ||
Stock options and other (in shares) | 4,194,000 | 4,398,000 |
Denominator for diluted earnings per share-adjusted weighted average shares outstanding | 158,467,000 | 159,094,000 |
Basic earnings per share: | ||
Net earnings attributable to the Company (in dollars per share) | $ 0.46 | $ 1.33 |
Diluted earnings per share: | ||
Net earnings attributable to the Company (in dollars per share) | $ 0.45 | $ 1.29 |
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares) | 621,013 | 222,946 |
Supplemental Cash Flow Inform_3
Supplemental Cash Flow Information (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Supplemental Cash Flow Information | |||
Amount of receivables sold | $ 525 | $ 515 | $ 542 |
Receivables sold under supply chain factoring program | 172 | 176 | 178 |
Interest paid in cash | 78 | 68 | |
Increase or decrease to cash from operating activities from factoring programs | 17 | (20) | |
Expense due to factoring program | 6 | 5 | |
Outstanding payment obligations to the financial institutions as part of SCF Programs | 94 | 120 | $ 113 |
Income taxes paid in cash | |||
Income taxes paid in cash | 36 | 41 | |
U.S. operations | |||
Income taxes paid in cash | |||
Income taxes paid in cash | 3 | 3 | |
Non-U.S. | |||
Income taxes paid in cash | |||
Income taxes paid in cash | $ 33 | $ 38 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ 72 | $ 206 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Mar. 31, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |